Hyperkalaemia is rarely the headline diagnosis, but is often the hidden reason behind suboptimal therapy. Safer, long-term management options are now offer clinicians a realistic path to restoring treatment continuity and stability for patients with chronic kidney disease and heart failure

Source: The Hindu